¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°è ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀº 2022³â ¾à 141¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 6.21% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀº À§»ýÀ» º¸ÀåÇÏ°í ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ¹æÁöÇϱâ À§ÇØ ÀÏȸ¿ë ÁÖ»ç±âÀÇ »ý»ê, À¯Åë ¹× ÆÇ¸Å¸¦ Æ÷°ýÇÏ´Â ¼¼°è »ê¾÷À¸·Î, ÀÏȸ¿ë ÁÖ»ç±â´Â 1ȸ »ç¿ë ÈÄ Æó±âÇϵµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀåÀº ¿Ü°ú ¼ö¼ú Áõ°¡¿Í ¸¸¼º Áúȯ À¯º´·üÀÇ ¼¼°èÀûÀÎ Áõ°¡¿Í °°Àº ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.
ÀÏȸ¿ë ÁÖ»ç±â´Â ÀÏȸ¿ë ÁÖ»ç±â´Â 1ȸ¿ëÀ¸·Î ¼³°èµÈ ÀÇ·á±â±â·Î, ÀÌÈÄ Æó±â¸¦ ÅëÇØ °¨¿° À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ±¹Á¦´ç´¢º´¿¬¸Í¿¡ µû¸£¸é 2021³â¿¡´Â 5¾ï 3,700¸¸ ¸íÀÇ ¼ºÀÎÀÌ ´ç´¢º´À» ¾Î¾ÒÀ¸¸ç, 10¸í Áß 1¸íÀº ´Ù¸¥ ´ç´¢º´À» ¾Î°í ÀÖ¾ú½À´Ï´Ù. 2045³â¿¡´Â 7¾ï 8,300¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌó·³ ´ç´¢º´ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ëÀÎ Àα¸¿Í ºñ¸¸ Àα¸´Â ¸¸¼º Áúȯ¿¡ °É¸®±â ½¬¿î °æÇâÀÌ ÀÖ½À´Ï´Ù. ¼¼°èÀºÇà ±×·ì¿¡ µû¸£¸é, 2020³â ¼¼°è ³ëÀÎ Àα¸´Â 7¾ï 2,700¸¸ ¸íÀ̾úÀ¸³ª ÇâÈÄ 30³â°£ 3¹è Áõ°¡ÇÏ¿© 2050³â¿¡´Â 15¾ï ¸í¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, °¨¿° °ü¸®¿¡ ´ëÇÑ ÀÇ·á°èÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÇ·áºñ Áõ°¡´Â ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¦´Â 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÏȸ¿ë ÁÖ»ç±â ¼¼°è ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àα¸ °í·ÉÈ¿Í ¸¸¼º ÁúȯÀÇ È®»êÀ¸·Î ÀÎÇØ 2022³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«Àº °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ÀÇ·á ÁöÃâ Áõ°¡¿Í Çö´ë½Ä ÀÇ·á ½Ã¼³ÀÇ ±Þ¼ÓÇÑ µµÀÔÀ¸·Î ÀÎÇÑ °ÍÀ¸·Î, ÀÌ Áö¿ªÀÇ ÀÇ·á ÀÎÇÁ¶ó ¹× Á¢±Ù¼º Çâ»óÀ¸·Î ÀüȯµÇ°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.
ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀû ±âȸ¿¡ ´ëÇØ¼µµ ´Ù·ç¾ú½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇöȲ
- ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2020-2030³â
- ÁÖ¿ä µ¿Çâ
- Á¶»ç ¹æ¹ý
- Á¶»çÀÇ ÀüÁ¦Á¶°Ç
Á¦2Àå ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ¸ñÀû
- ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ´ë»ó³âµµ
- ÅëÈ È¯»êÀ²
Á¦3Àå ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ¿ªÇÐ
- ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- ½ÃÀå ±âȸ
Á¦4Àå ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå »ê¾÷ ºÐ¼®
- Porter's Five Forces ¸ðµ¨
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ¹ÙÀ̾îÀÇ ±³¼··Â
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï ±â¾÷°£ °æÀï °ü°è
- Porter's Five ForcesÀÇ ¿µÇ⠺м®
- PEST ºÐ¼®
- Á¤Ä¡
- °æÁ¦
- »çȸ
- 񃬣
- ȯ°æ
- ¹ý·ü
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ÁÖ¿ä ¼º°ø Àü·«
- COVID-19ÀÇ ¿µÇ⠺м®
- ÆÄ±«Àû µ¿Çâ
- ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
- ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È
Á¦5Àå ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : Á¦Ç°º°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : Á¦Ç°º°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø2020-2030³â
- ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
Á¦6Àå ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : ¿ëµµº°
- ½ÃÀå ÇöȲ
- ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : ¿ëµµº°, ½ÇÀû-°¡´É¼º ºÐ¼®
- ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå, ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø2020-2030
- ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
- ¿¹¹æ¿ë ½Ã¸°Áö
- Ä¡·á¿ë ½Ã¸°Áö
Á¦7Àå ¼¼°èÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå : Áö¿ªº° ºÐ¼®
- ÁÖ¿ä ±¹°¡
- ÁÖ¿ä ½ÅÈï ±¹°¡
- ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
- ºÏ¹Ì
- ¹Ì±¹
- Á¦Ç° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
- ij³ª´Ù
- À¯·´ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ÇöȲ
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ÇöȲ
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÀÏȸ¿ë ÁÖ»ç±â ½ÃÀå ÇöȲ
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï Á¤º¸
- ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
- ÁÖ¿ä ½ÃÀå Àü·«
- ±â¾÷ °³¿ä
- Nipro Corporation
- ÁÖ¿ä Á¤º¸
- °³¿ä
- À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
- Á¦Ç° °³¿ä
- ÃÖ±Ù µ¿Çâ
- Fresenius Kabi AG
- Baxter International, Inc.
- B. Braun Melsungen AG
- Terumo Corporation
- Novo Nordisk
- UltiMed, Inc.
- Henke-Sass, Wolf
- Retractable Technologies Inc.
- Vita Needle Company
Á¦9Àå Á¶»ç °úÁ¤
- Á¶»ç °úÁ¤
- µ¥ÀÌÅÍ ¸¶ÀÌ´×
- ºÐ¼®
- ½ÃÀå ÃßÁ¤
- °ËÁõ
- ÃâÆÇ
- Á¶»ç ¼Ó¼º
- Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 23.08.04
Global Disposable Syringes Market is valued at approximately USD 14.1 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.21% over the forecast period 2023-2030. The Disposable Syringes Market refers to the global industry encompassing the production, distribution, and sale of single-use syringes, which are designed for one-time use and subsequent disposal to ensure hygiene and prevent the risk of cross-contamination. The Disposable Syringes Market is being driven by factors such as an Increase in the number of surgical procedures and a Global increase in the prevalence of chronic diseases.
Disposable syringes are medical devices designed for single-use applications and subsequent disposal reduces the risk of infection. According to the International Diabetes Federation, 537 million adults were living with diabetes in 2021, with one in ten experiencing other diabetes, and it is projected to reach at 783 million cases by year 2045. Thus, rising prevelance of diabetes is driving the market growth. Furthermore, geriatric, and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. In addition to Increasing awareness about infection control and increasing healthcare expenditure may create lucrative opportunities for the market. However, Stringent Government regulations may hinder the growth of the market throughout the forecast period of 2023-2030.
The key regions considered for the Global Disposable Syringes Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Asia Pacific dominated the market in 2022 owing to the aging population and growing prevalence of chronic diseases. Middle East and Africa region is projected to experience the highest growth rate. This growth can be attributed to increased healthcare expenditures and the rapid adoption of modern healthcare facilities, indicating a shift towards improved healthcare infrastructure and accessibility in the region.
Major market player included in this report are:
- Nipro Corporation
- Fresenius Kabi AG
- Baxter International, Inc.
- B. Braun Melsungen AG
- Terumo Corporation
- Novo Nordisk
- UltiMed, Inc.
- Henke-Sass, Wolf
- Retractable Technologies Inc.
- Vita Needle Company
Recent Developments in the Market:
- In October 2022, Terumo Pharmaceutical Solutions launched introduction of ready-to-fill polymer syringe, designed for challenging biotech drugs and featuring an increased volume capacity, is poised to disrupt the market by addressing a critical need in the pharmaceutical industry and enhancing drug delivery for complex medications.
Global Disposable Syringes Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimation: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product, Application, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
- Conventional Syringes
- Safety Syringes
By Application:
- Immunization Injections
- Therapeutic Injections
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Disposable Syringes Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Disposable Syringes Market, by Product, 2020-2030 (USD Billion)
- 1.2.3. Disposable Syringes Market, by Application, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Disposable syringes Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Disposable syringes Market Dynamics
- 3.1. Disposable Syringes Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increase in the number of surgical procedures.
- 3.1.1.2. Global increase in the prevalence of chronic diseases.
- 3.1.2. Market Challenges
- 3.1.2.1. High Cost of Disposable Syringes
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing awareness about infection control.
- 3.1.3.2. Increasing healthcare expenditure
Chapter 4. Global Disposable syringes Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Disposable syringes Market, by Product
- 5.1. Market Snapshot
- 5.2. Global Disposable Syringes Market by Product, Performance - Potential Analysis
- 5.3. Global Disposable Syringes Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
- 5.4. Disposable Syringes Market, Sub Segment Analysis
- 5.4.1. Conventional Syringes
- 5.4.2. Safety Syringes
Chapter 6. Global Disposable syringes Market, by Application
- 6.1. Market Snapshot
- 6.2. Global Disposable Syringes Market by Application, Performance - Potential Analysis
- 6.3. Global Disposable Syringes Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
- 6.4. Disposable Syringes Market, Sub Segment Analysis
- 6.4.1. Immunization Injections
- 6.4.2. Therapeutic Injections
Chapter 7. Global Disposable syringes Market, Regional Analysis
- 7.1. Top Leading Countries
- 7.2. Top Emerging Countries
- 7.3. Disposable Syringes Market, Regional Market Snapshot
- 7.4. North America Disposable Syringes Market
- 7.4.1. U.S. Disposable Syringes Market
- 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
- 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 7.4.2. Canada Disposable Syringes Market
- 7.5. Europe Disposable Syringes Market Snapshot
- 7.5.1. U.K. Disposable Syringes Market
- 7.5.2. Germany Disposable Syringes Market
- 7.5.3. France Disposable Syringes Market
- 7.5.4. Spain Disposable Syringes Market
- 7.5.5. Italy Disposable Syringes Market
- 7.5.6. Rest of Europe Disposable Syringes Market
- 7.6. Asia-Pacific Disposable Syringes Market Snapshot
- 7.6.1. China Disposable Syringes Market
- 7.6.2. India Disposable Syringes Market
- 7.6.3. Japan Disposable Syringes Market
- 7.6.4. Australia Disposable Syringes Market
- 7.6.5. South Korea Disposable Syringes Market
- 7.6.6. Rest of Asia Pacific Disposable Syringes Market
- 7.7. Latin America Disposable Syringes Market Snapshot
- 7.7.1. Brazil Disposable Syringes Market
- 7.7.2. Mexico Disposable Syringes Market
- 7.8. Middle East & Africa Disposable Syringes Market
- 7.8.1. Saudi Arabia Disposable Syringes Market
- 7.8.2. South Africa Disposable Syringes Market
- 7.8.3. Rest of Middle East & Africa Disposable Syringes Market
Chapter 8. Competitive Intelligence
- 8.1. Key Company SWOT Analysis
- 8.1.1. Company 1
- 8.1.2. Company 2
- 8.1.3. Company 3
- 8.2. Top Market Strategies
- 8.3. Company Profiles
- 8.3.1. Nipro Corporation
- 8.3.1.1. Key Information
- 8.3.1.2. Overview
- 8.3.1.3. Financial (Subject to Data Availability)
- 8.3.1.4. Product Summary
- 8.3.1.5. Recent Developments
- 8.3.2. Fresenius Kabi AG
- 8.3.3. Baxter International, Inc.
- 8.3.4. B. Braun Melsungen AG
- 8.3.5. Terumo Corporation
- 8.3.6. Novo Nordisk
- 8.3.7. UltiMed, Inc.
- 8.3.8. Henke-Sass, Wolf
- 8.3.9. Retractable Technologies Inc.
- 8.3.10. Vita Needle Company
Chapter 9. Research Process
- 9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
- 9.2. Research Attributes
- 9.3. Research Assumption